News and Events - Cardionovum®

Latest press release

Feb 17, 2016

RESTORE clinical study results on in-stent restenosis.

Cardionovum experiences increase in demand for its innovative, and next generation „RESTORE Paclitaxel-releasing coronary balloon dilatation catheter.“ The American Journal of Cardiology, issue December 2015, published study results on the efficacy and safety of Paclitaxel coated balloon catheters for the treatment of in-stent restenosis in high risk patients. The RESTORE DEB showed significant superiority with lowest incidence of restenosis, if compared to other contemporary coronary DEBs.

Learn more >> RESTORE clinical study results on in-stent restenosis.

Feb 01, 2016

Cardionovum at LINC 2016

Dr. Jean Paul de Vries (PI) presented the patient study results of the multi-center randomized RAPID trial.

Learn more >> Cardionovum at LINC 2016

Dec 04, 2015

Early APERTO patient results look promising.

Cardionovum prepares for a first international publication on 6-12 months FU patient results from the ongoing APERTO clinical study program. The APERTO Paclitaxel-releasing high pressure shunt balloon dilatation catheter was exclusively designed to treat shunt stenosis of hemodialysis patients.

Learn more >> Early APERTO patient results look promising.

Upcoming events

Currently there are no events.

Latest events

Cardionovum at CIRSE 2021 Cardionovum at CIRSE 2021

Cardionovum invites you to participate in 3 scientific presentations in the "Technology Innovations Videos":

Sunday 26th
The SAFEPAX Technology presented by Dr. Michael Lichtenberg.
Monday 27th
The Reflow Study at 2 years follow up. by Dr. Marc Bosiers.
Tuesday 28th
Clinical outcomes with APERTO Balloon. by Dr. Matteo Tozzi.

Date: Sep 25, 2021–Sep 29, 2021

Cardionovum at CIRSE 2021 Learn more >>

Cardionovum at EuroPCR 18, 19, 20 May 2021 Cardionovum at EuroPCR 18, 19, 20 May 2021

Cardionovum invites you to participate in on demand interviwes:

XLIMIT Trial RCT, with Dr. Luca Testa from Italy.
Goal: to assess angiographic and clinical performance of the Xlimus Biodegradable Polymer Sirolumus-eluting stent versus a gold standard like Synergy Biodegradable Polymer Everolimus Stent in patients treated with percutaneous coronary angioplasty.
Hyper Registry with Dr. Alfonso Ileasi from Italy.
Goal: Asses the clinical results after a Hybrid Approach in diffuse CAD lesions longer tan 28mm combinig Restore DCB and New generation DES.

Date: May 18, 2021–May 21, 2021

Cardionovum at EuroPCR 18, 19, 20 May 2021 Learn more >>